GLS and autoimmune hepatitis: In conclusion, we have demonstrated that GLS blocking reduces the activation and differentiation of T cells and disease severity in ConA-induced AIH mice, via reducing the mRNA expression of SLC7A5, lowering the level of intracellular leucine and further inhibiting the activation of mTOR signaling.